Acromegaly induced by ectopic secretion of GHRH: A review 30 years after GHRH discovery

Annales d'Endocrinologie

Volumn 73, Issue 6, 2012, Pages 497-502

  Borson Chazot, Françoise ^a   Garby, Laetitia ^a   Raverot, Gerald ^a   Claustrat, Francine ^a   Raverot, Véronique ^a   Sassolas, Geneviève ^a  

^a HOSPICES CIVILS DE LYON   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE RELEASING FACTOR;

ACROMEGALY; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; ENDOCRINE SURGERY; GROWTH HORMONE RELEASE; GROWTH HORMONE SECRETING ADENOMA; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; NONHUMAN; PROGNOSIS; TUMOR LOCALIZATION;

ACROMEGALY; ANIMALS; BRONCHIAL NEOPLASMS; GASTROINTESTINAL NEOPLASMS; GENETIC ASSOCIATION STUDIES; GROWTH HORMONE-RELEASING HORMONE; HUMANS; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PARANEOPLASTIC ENDOCRINE SYNDROMES; TIME FACTORS;

EID: 84872407597     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ando.2012.09.004     Document Type: Article

References (38)

1. Losa M., Schopohl J., von Werder K. Ectopic secretion of growth hormone-releasing hormone in man. J Endocrinol Invest 1993, 16:69-81.
2. Sano T., Asa S.L., Kovacs K. Growth hormone-releasing hormone-producing tumors: clinical, biochemical, and morphological manifestations. Endocr Rev 1988, 9:357-373.
3. Gola M., Doga M., Bonadonna S., Mazziotti G., Vescovi P.P., Giustina A. Neuroendocrine tumors secreting growth hormone-releasing hormone: pathophysiological and clinical aspects. Pituitary 2006, 9:221-229.
4. Garby L., Caron P., Claustrat F., Chanson P., Tabarin A., Rohmer V., et al. Clinical characteristics and outcome of acromegaly induced by ectopic secretion of growth hormone-releasing hormone (GHRH): a French nationwide series of 21 cases. J Clin Endocrinol Metab 2012, 97:2093-2104.
5. Guillemin R., Brazeau P., Böhlen P., Esch F., Ling N., Wehrenberg W.B. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 1982, 218:585-587.
6. Rivier J., Spiess J., Thorner M., Vale W. Characterization of a growth hormone-releasing factor from a human pancreatic islet tumor. Nature 1982, 300:276-278.
7. Sassolas G., Chayvialle J.A., Partensky C., Berger G., Trouillas J., Berger F., et al. Acromegaly, clinical expression of the production of growth hormone-releasing factor in pancreatic tumors. Ann Endocrinol (Paris) 1983, 44:347-354.
8. Wehrenberg W.B., Ling N. In vivo biological potency of rat and human growth hormone-releasing factor and fragments of human growth hormone-releasing factor. Biochem Biophys Res Commun 1983, 115:525-530.
9. Frohman L.A., Downs T.R., Williams T.C., Heimer E.P., Pan Y.C., Felix A.M. Rapid enzymatic degradation of growth hormone-releasing hormone by plasma in vitro and in vivo to a biologically inactive product cleaved at the NH2 terminus. J Clin Invest 1986, 78:906-913.
10. Thorner M.O., Perryman R.L., Cronin M.J., Rogol A.D., Draznin M., Johanson A., et al. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 1982, 70:965-977.
11. Spiess J., Rivier J., Thorner M., Vale W. Sequence analysis of a growth hormone-releasing factor from a human pancreatic islet tumor. Biochemistry 1982, 21:6037-6040.
12. Böhlen P., Brazeau P., Bloch B., Ling N., Gaillard R., Guillemin R. Human hypothalamic growth hormone-releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40. Biochem Biophys Res Commun 1998, 114:930-936.
13. Ling N., Esch F., Böhlen P., Brazeau P., Wehrenberg W.B., Guillemin R. Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc Natl Acad Sci U S A 1984, 81:4302-4306.
14. Barabutis N., Schally A.V. Growth hormone-releasing hormone, extrapituitary effects in physiology and pathology. Cell Cycle 2010, 9:4110-4116.
15. Schally A.V., Varga J.L., Engel J.B. Antagonists of growth hormone-releasing hormone: an emerging new therapy for cancer. Nat Clin Pract Endocrinol Metab 2008, 4:33-43.
16. Ludwig B., Ziegler C.G., Schally A.V., Richter C., Steffen A., Jabs N., et al. Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. Proc Natl Acad Sci U S A 2010, 107:12623-21268.
17. Kanashiro-Takeuchi R.M., Tziomalos K., Takeuch L.M., Treuer A.V., Lamirault G., Dulce R., et al. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc Natl Acad Sci U S A 2010, 107:2604-2609.
18. Van den Bruel A., Fevery J., Van Dorpe J., Hofland L., Bouillon R. Hormonal and volumetric long-term control of a growth hormone-releasing hormone-producing carcinoid tumor. J Clin Endocrinol Metab 1999, 84:3162-3169.
19. Faglia G., Arosio M., Bazzoni N. Ectopic acromegaly. Endocrinol Metab Clin North Am 1992, 21:575-595.
20. Sasaki A., Sato S., Yumita S., Hanew K., Miura Y., Yoshinaga K. Multiple forms of immuno-reactive growth hormone-releasing hormone in human plasma, hypothalamus, and tumor tissues. J Clin Endocrinol Metab 1989, 68:180-185.
21. Bostwick D.G., Quan R., Hoffman A.R., Webber R.J., Chang J.K., Bensch K.G. Growth hormone-releasing factor immuno-reactivity in human endocrine tumors. Am J Pathol 1984, 117:167-170.
22. Christofides N.D., Stephanou A., Suzuki H., Yiangou Y., Bloom S.R. Distribution of immuno-reactive growth hormone-releasing hormone in the human brain and intestine and its production by tumors. J Clin Endocrinol Metab 1984, 59:747-751.
23. Asa S.L., Kovacs K., Thorner M.O., Leong D.A., Rivier J., Vale W. Immunohistological localization of growth hormone-releasing hormone in human tumors. J Clin Endocrinol Metab 1985, 60:423-427.
24. Dayal Y., Lin H.D., Tallberg K., Reichlin S., De Lellis R.A., Wolfe H.J. Immunocytochemical demonstration of growth hormone-releasing factor in gastrointestinal and pancreatic endocrine tumors. Am J Clin Pathol 1986, 85:13-20.
25. Schulte H.M., Benker G., Windeck R., Olbricht T., Reinwein D. Failure to respond to growth hormone-releasing hormone (GHRH) in acromegaly due to a GHRH secreting pancreatic tumor: dynamics of multiple endocrine testing. J Clin Endocrinol Metab 1985, 61:585-587.
26. Barkan A.L., Shenker Y., Grekin R.J., Vale W.W., Lloyd R.V., Beals T.F. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion. J Clin Endocrinol Metab 1986, 63:1057-1064.
27. Asa S.L., Scheithauer B.W., Bilbao J.M., Horvath E., Ryan N., Kovacs K., et al. A case for hypothalamic acromegaly: a clinicopathological study of six patients with hypothalamic gangliocytomas producing growth hormone-releasing factor. J Clin Endocrinol Metab 1984, 58:796-803.
28. Asa S.L., Kovacs K., Stefaneanu L., Horvath E., Billestrup N., Gonzalez-Manchon C., et al. Pituitary adenomas in mice transgenic for growth hormone-releasing hormone. Endocrinology 1992, 131:2083-2089.
29. Shintani Y., Yoshimoto K., Horie H., Sano T., Kanesaki Y., Hosoi E., et al. Two different pituitary adenomas in a patient with multiple endocrine neoplasia type 1 associated with growth hormone-releasing hormone-producing pancreatic tumor: clinical and genetic features. Endocr J 1995, 42:331-340.
30. Nasr C., Mason A., Mayberg M., Staugaitis S.M., Asa S.L. Acromegaly and somatotroph hyperplasia with adenomatous transformation due to pituitary metastasis of a growth hormone-releasing hormone-secreting pulmonary endocrine carcinoma. J Clin Endocrinol Metab 2006, 91:4776-4780.
31. Thorner M.O., Frohman L.A., Leong D.A., Thominet J., Downs T., Hellmann P., et al. Extrahypothalamic growth hormone-releasing factor (GRF) secretion is a rare cause of acromegaly: plasma GRF levels in 177 acromegalic patients. J Clin Endocrinol Metab 1984, 59:846-849.
32. Girard P., Cohen R., Sassolas G., Harthe C., Cabrera P., Boissel J.P. Pharmacokinetics of human growth hormone-releasing factor (hGRF-44-NH2) in normal men after intravenous administration of a large range of doses. Eur J Clin Pharmacol 1987, 32:507-513.
33. Penny E.S., Penman E., Price J., Rees L.H., Sopwith A.M., Wass J.A., et al. Circulating growth hormone-releasing factor concentrations in normal subjects and patients with acromegaly. Br Med J (Clin Res Ed) 1984, 289:453-455.
34. Oberg K., Jelic S. Neuroendocrine gastro-enteropancreatic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up. Ann Oncol 2009, 20(Suppl. 4):150-153.
35. Oberg K., Jelic S. Neuroendocrine bronchial and thymic tumors: ESMO clinical recommendation for diagnosis, treatment and follow-up. Ann Oncol 2009, 20(Suppl. 4):147-149.
36. Barkan A.L., Shenker Y., Grekin R.J., Vale W.W. Acromegaly from ectopic growth hormone-releasing hormone secretion by a malignant carcinoid tumor. Successful treatment with long-acting somatostatin analogue SMS 201-995. Cancer 1988, 61:221-226.
37. Wilson D.M., Ceda G.P., Bostwick D.G., Webber R.J., Minkoff J.R., Pont A., et al. Acromegaly and Zollinger-Ellison syndrome secondary to an islet cell tumor: characterization and quantification of plasma and tumor human growth hormone-releasing factor. J Clin Endocrinol Metab 1984, 59:1002-1005.
38. Lefebvre S., De Paepe L., Abs R., Rahier J., Selvais P., Maiter D. Subcutaneous octreotide treatment of a growth hormone-releasing hormone-secreting bronchial carcinoid: superiority of continuous versus intermittent administration to control hormonal secretion. Eur J Endocrinol 1995, 133:320-324.